drugset / Trial / NCT06115031

Remimazolam vs. Propofol: Impact on Postoperative Delirium in Neurosurgical Patients

NCT06115031

Completed 696 enrolled Samsung Medical Center
RandomizedParallel-groupTriple-blindPrevention

Summary

The investigator aimed to evaluate the incidence of postoperative delirium after remimazolam-based total intravenous anesthesia (TIVA) compared to the propofol-based TIVA in patients undergoing neurosurgery.

Timeline

Start
2023-11-13
Primary completion
2025-11-24
Completion
2026-02-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule Intravenous
Subject Remimazolam Small molecule 0.6 mg/kg Intravenous
Subject Remimazolam Small molecule 2 mg/kg Intravenous

Indications